PHOSLYRA

Peak

calcium acetate

NDAORALSOLUTION
Approved
Apr 2011
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
1

Clinical Trials (1)

NCT00196755Phase 3Completed

Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis

Started Dec 2004
138 enrolled
Peritoneal DialysisChronic Kidney Disease

Loss of Exclusivity

LOE Date
Feb 23, 2030
48 months away
Patent Expiry
Feb 23, 2030

Patent Records (3)

Patent #ExpiryTypeUse Code
8592480
Jul 20, 2027
U-1469
9089528
Jul 20, 2027
U-1469
8591938
Feb 23, 2030
Product
U-1469